Single - dose immunization of human subjects against tetanus

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• Tetanus remains a significant public health concern, necessitating effective immunization strategies.
• Traditional tetanus immunization schedules may be lengthy, impacting adult compliance and population-wide protection.

Purpose of the Study:

• To evaluate the efficacy of a single-dose tetanus toxoid immunization followed by a booster one year later.
• To determine the duration of protective antitoxin levels after primary immunization.
• To assess the response to a reduced-dose booster immunization.

Main Methods:

• A cohort of 283 students with no pre-existing tetanus antitoxin was selected.
• Primary immunization with 20 CU of adsorbed tetanus toxoid was administered.
• Antitoxin titers were monitored at 10-15 days post-immunization and annually.
• A subset of 109 participants received a 10 CU booster dose after one year, with post-revaccination titers assessed.

Main Results:

• Single-dose immunization induced a gradual rise in antitoxin titers to protective levels, maintained for one year.
• Revaccination with 10 CU of tetanus toxoid resulted in a 100-197 fold increase in antitoxin titers within 10-15 days, exceeding protective thresholds.
• The study demonstrated sustained protective immunity for one year post-initial vaccination.

Conclusions:

• A single dose of 20 CU adsorbed tetanus toxoid provides a year of protective immunity in previously unimmunized adults.
• A reduced booster dose of 10 CU elicits a robust and rapid increase in antitoxin levels.
• These findings support the potential for a shortened tetanus immunization schedule for adult populations, enhancing prophylaxis effectiveness.